Swan Capital LLC Abbott Laboratories Transaction History
Swan Capital LLC
- $205 Billion
- Q4 2024
A detailed history of Swan Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Swan Capital LLC holds 189 shares of ABT stock, worth $24,549. This represents 0.01% of its overall portfolio holdings.
Number of Shares
189
Previous 189
-0.0%
Holding current value
$24,549
Previous $21.5 Million
0.79%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,375Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$21.9 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$8.83 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.03 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $227B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...